Advisor appointed as SKN ramps up acquisition strategy
Australian natural skin care company Skin Elements Limited (ASX:SKN) has today announced the appointment of corporate advisory firm MMR Corporate Services Pty Ltd as corporate advisors to drive its acquisition strategy in the global natural skin care market.
SKN will be engaging MMR Corporate to act as corporate advisors and transaction facilitators as the company looks to accelerate the acquisition component of its growth model.
As part of the agreement, MRR will advise SKN on capital raising strategies, access to funding facilities, and any required support surrounding a possible transaction.
Under the engagement, MMR will closely work with SKN’s team, in particular the Executive Chairperson Peter Malone, to source and execute high-value merger and acquisition opportunities. The scope for SKN spans companies in Australia and other parts of the world operating in skincare, cosmetics or related sectors.
It’s worth noting here that SKN is an early stage play and investors should seek professional financial advice if considering this company for their portfolio.
With several products on the market spanning organic sunscreen, natural skincare treatments, and an all-natural cosmetics product range in the pipeline, SKN is focused on becoming a recognised international leader in the field and rapidly growing its market reach.
Specifically, its growth model is based on delivering sustained sales growth, entering new markets, developing its pipeline products and acquiring complementary, value-accretive companies. In May last year SKN executed its acquisition plans, successfully purchasing McArthur Skincare.
It is now in discussions with groups in south-east Asia and the Middle East in relation to potential acquisition, joint venture and distribution agreements related to skincare products. In addition to helping SKN secure transactions, MMR will also assist in maximising the commercial benefits of any acquisition. The company will release ongoing updates on any future developments to come out of these discussions.
Skin Elements Executive Chairperson Peter Malone said: “Skin Elements has been impressed with the results MMR Corporate has delivered in successfully sourcing capital and developing new business opportunities for emerging Australian growth companies.
“Their track record and capacity in this area is attractive, and we look forward to working closely with the MMR Corporate team to deliver successful acquisition outcomes for the benefit of the Company and our shareholders.”
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.